百洋医药 (301015.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(百洋医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 1,661,158,413.817,563,902,600.835,495,813,532.483,634,743,980.601,686,422,354.667,509,618,040.765,519,525,478.093,730,497,140.171,860,324,319.90
 营业利润(元) 218,925,313.31888,103,896.46647,844,165.88395,534,378.19155,919,014.38674,258,115.78471,818,891.70294,404,659.91119,548,290.30
 利润总额(元) 217,571,121.59873,577,654.17648,048,399.13395,688,633.00156,259,665.28668,549,805.98467,188,283.77292,930,065.66120,256,330.64
 净利润(元) 164,996,276.84639,883,332.35484,236,458.68292,640,460.30119,549,046.03485,404,303.31335,393,953.51209,031,259.3187,633,289.75
 归属于母公司股东的净利润(元) 165,994,250.13656,305,764.05494,146,784.62302,475,213.26122,413,769.52502,089,121.05343,690,319.23214,797,953.4188,437,711.29
盈利能力:
 销售毛利率(%) 29.7529.9829.3329.6428.9127.7626.8226.6125.61
 销售净利率(%) 9.938.468.818.057.096.466.085.604.71
 净资产收益率(%) 6.3126.4121.0813.895.24----
 总资产报酬率ROA(%) 4.2618.0013.458.433.50----
 投入资本回报率ROIC(%) 3.7816.3212.307.413.1013.449.396.082.42
营运能力:
 存货周转率(次) 1.677.945.664.191.78----
 应收账款周转率(次) 0.873.692.701.820.86----
 总资产周转率(次) 0.311.461.080.730.35----
偿债能力:
 资产负债率(%) 50.3050.1352.9857.3552.8454.6856.2155.1751.69
 股东权益比率(%) 50.1850.3647.4143.2547.6845.7644.2044.3047.94
 已获利息倍数(倍) 20.8316.6517.6717.5211.6514.8215.2512.519.50
 流动比率 2.402.452.312.041.691.641.601.631.74
 速动比率 1.941.961.821.641.321.291.241.291.42
发展能力:
 营业收入增长率(%) -1.500.72-0.43-2.57-9.356.505.4311.5014.43
 营业利润增长率(%) 40.4131.7237.3134.3532.0420.0915.9516.154.21
 税后利润增长率(%) 35.6029.5543.2939.7639.7819.0811.4514.582.79
 净资产增长率(%) 16.9215.9318.6216.047.996.710.980.6944.12
 总资产增长率(%) 11.105.3410.5818.858.569.283.502.8617.17

前瞻产业研究院